Comera Life Sciences Holdings, Inc. (CMRA): Price and Financial Metrics

Comera Life Sciences Holdings, Inc. (CMRA): $0.00

0.00 (200.00%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

D

Add CMRA to Watchlist
Sign Up

Industry: Biotech

Industry

NR

Ranked

#367 of 378

in industry

CMRA Price/Volume Stats

Current price $0.00 52-week high $0.13
Prev. close $0.00 52-week low $0.00
Day low $0.00 Volume 122,800
Day high $0.00 Avg. volume 18,571
50-day MA $0.02 Dividend yield N/A
200-day MA $0.11 Market Cap 9.22K

CMRA Stock Price Chart Interactive Chart >


Comera Life Sciences Holdings, Inc. (CMRA) Company Bio


Comera Life Sciences Holdings, Inc. operates as a pre-clinical biotechnology company. It develops an internal portfolio of proprietary therapeutics that incorporate its proprietary formulation platform, SQore. The company's SQore platform is designed to enable the conversion of intravenous (IV) biologics to subcutaneous (SQ) versions. Its products pipeline include CLS-001, an SQ formulation of a marketed, IV administered monoclonal antibody therapeutic for Crohn's disease and ulcerative colitis; CLS-002, an SQ formulation of a marketed, IV-administered immuno-oncology targeted monoclonal antibody for various oncology indications. The company was founded in 2014 and is based in Woburn, Massachusetts.


CMRA Latest News Stream


Event/Time News Detail
Loading, please wait...

CMRA Latest Social Stream


Loading social stream, please wait...

View Full CMRA Social Stream

CMRA Price Returns

1-mo 0.00%
3-mo N/A
6-mo N/A
1-year 0.00%
3-year N/A
5-year N/A
YTD 0.00%
2023 -95.53%
2022 N/A
2021 N/A
2020 N/A
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!